Rentokil Initial (RTO) Stock Price, News & Analysis

Company Overview

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments. Utilising proprietary digital monitoring tools and integrated pest management techniques, Rentokil aims to provide long-term, environmentally responsible solutions.

The Initial division delivers a suite of hygiene and workwear products and services. This includes washroom and sanitary services, cleanroom supply and maintenance for regulated industries, plus the rental, laundering and repair of workwear, mats and protective equipment. The division supports businesses across sectors such as hospitality, retail, manufacturing and healthcare, with a focus on compliance, safety and sustainability.

Founded as Rentokil in 1925, the company expanded through a series of strategic acquisitions and in 1997 merged with Initial, a leading provider of hygiene services. Today Rentokil Initial operates in more than 60 countries across Europe, North America, Latin America, the Asia-Pacific region and the Middle East. Led by Chief Executive Officer Andy Ransom since 2018, the company continues to pursue growth through innovation, digital transformation and a commitment to reducing environmental impact.

Key Stats

• Today's Range: $29.85 to $30.43
• 50-Day Range: $28.36 to $32.24
• 52-Week Range: $22.77 to $34.67
• Volume: 464,452 shs
• Average Volume: 704,416 shs
• Market Capitalization: $15.08 billion
• P/E Ratio: N/A
• Dividend Yield: 2.41%
• Price Target: $34.50
• Consensus Rating: Moderate Buy

Rentokil Initial Stock Analysis - MarketRank™

Rentokil Initial scored higher than 85% of companies evaluated by MarketBeat, and ranked 57th out of 290 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Rentokil Initial has received a consensus rating of Moderate Buy. The company's average rating score is 2.54, and is based on 1 strong buy rating, 7 buy ratings, 3 hold ratings, and 2 sell ratings.

Upside Potential

Rentokil Initial has a consensus price target of $34.50, representing about 15.6% upside from its current price of $29.86.

Amount of Analyst Coverage

Rentokil Initial has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 17.27%

Earnings Growth

Earnings for Rentokil Initial are expected to grow by 17.27% in the coming year, from $1.10 to $1.29 per share.

Price to Earnings Growth Ratio

Rentokil Initial has a PEG Ratio of 2.17. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Rentokil Initial has a P/B Ratio of 2.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.44% of the float of Rentokil Initial has been sold short.

Short Interest Ratio / Days to Cover

Rentokil Initial has a short interest ratio ("days to cover") of 2.55, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Rentokil Initial has recently decreased by 22.70%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Rentokil Initial pays a meaningful dividend of 2.41%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Rentokil Initial does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Rentokil Initial will have a dividend payout ratio of 55.81% next year. This indicates that Rentokil Initial will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.3 / 5
• News Sentiment: 0.84

News Sentiment

Rentokil Initial has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Rentokil Initial this week, compared to 1 article on an average week.

Search Interest

3 people have searched for RTO on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Rentokil Initial to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rentokil Initial insiders have not sold or bought any company stock.

Percentage Held by Institutions

9.91% of the stock of Rentokil Initial is held by institutions.

Company Calendar

• Last Earnings: 8/06/2020
• Record date for 5/19 Dividend: 4/10/2026
• Ex-Dividend for 5/19 Dividend: 4/10/2026
• Dividend Payable: 5/19/2026
• Today: 7/22/2026
• Next Earnings (Estimated): 7/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Business Services
• Industry: BUSINESS SVCS
• Sub-Industry: Business Services
• Current Symbol: NYSE:RTO
• CIK: 930157
• Web: www.rentokil-initial.com
• Phone: 441293858000
• Fax: N/A
• Employees: 63,388
• Year Founded: 1925

Price Target and Rating

• Average Price Target for Rentokil Initial: $34.50
• High Price Target: $35.00
• Low Price Target: $34.00
• Potential Upside/Downside: +15.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.54
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 27.14
• P/E Growth: 2.17
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.76
• Current Ratio: 1.16
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $6.91 billion
• Price / Sales: 2.18
• Cash Flow: $2.32 per share
• Price / Cash Flow: 12.85
• Book Value: $10.88 per share
• Price / Book: 2.74

Miscellaneous

• Outstanding Shares: 505,210,000
• Free Float: N/A
• Market Cap: $15.08 billion
• Optionable: Not Optionable
• Beta: 0.97